Global Quinolone Antibiotic Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Quinolone Antibiotic market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Quinolone Antibiotic include Merck, Hebei Guangren Pharmaceutical Technology, Tianjin Glory Technology, Mercury Medicare and Healthy Life Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Quinolone Antibiotic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Quinolone Antibiotic, also provides the sales of main regions and countries. Of the upcoming market potential for Quinolone Antibiotic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Quinolone Antibiotic sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Quinolone Antibiotic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Quinolone Antibiotic sales, projected growth trends, production technology, application and end-user industry.
Quinolone Antibiotic Segment by Company
Merck
Hebei Guangren Pharmaceutical Technology
Tianjin Glory Technology
Mercury Medicare
Healthy Life Pharma
Quinolone Antibiotic Segment by Type
Levofloxacin
Ofloxacin
Norfloxacin
Moxifloxacin
Gatifloxacin
Ciprofloxacin
Others
Quinolone Antibiotic Segment by Application
Clinics
Hospital
Research
Others
Quinolone Antibiotic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolone Antibiotic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quinolone Antibiotic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolone Antibiotic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Quinolone Antibiotic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quinolone Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Quinolone Antibiotic market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Quinolone Antibiotic include Merck, Hebei Guangren Pharmaceutical Technology, Tianjin Glory Technology, Mercury Medicare and Healthy Life Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Quinolone Antibiotic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Quinolone Antibiotic, also provides the sales of main regions and countries. Of the upcoming market potential for Quinolone Antibiotic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Quinolone Antibiotic sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Quinolone Antibiotic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Quinolone Antibiotic sales, projected growth trends, production technology, application and end-user industry.
Quinolone Antibiotic Segment by Company
Merck
Hebei Guangren Pharmaceutical Technology
Tianjin Glory Technology
Mercury Medicare
Healthy Life Pharma
Quinolone Antibiotic Segment by Type
Levofloxacin
Ofloxacin
Norfloxacin
Moxifloxacin
Gatifloxacin
Ciprofloxacin
Others
Quinolone Antibiotic Segment by Application
Clinics
Hospital
Research
Others
Quinolone Antibiotic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolone Antibiotic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quinolone Antibiotic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolone Antibiotic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Quinolone Antibiotic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quinolone Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
189 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Quinolone Antibiotic Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Quinolone Antibiotic Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Quinolone Antibiotic Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Quinolone Antibiotic Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Quinolone Antibiotic Market Dynamics
- 2.1 Quinolone Antibiotic Industry Trends
- 2.2 Quinolone Antibiotic Industry Drivers
- 2.3 Quinolone Antibiotic Industry Opportunities and Challenges
- 2.4 Quinolone Antibiotic Industry Restraints
- 3 Quinolone Antibiotic Market by Manufacturers
- 3.1 Global Quinolone Antibiotic Revenue by Manufacturers (2020-2025)
- 3.2 Global Quinolone Antibiotic Sales by Manufacturers (2020-2025)
- 3.3 Global Quinolone Antibiotic Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Quinolone Antibiotic Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Quinolone Antibiotic Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Quinolone Antibiotic Manufacturers, Product Type & Application
- 3.7 Global Quinolone Antibiotic Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Quinolone Antibiotic Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Quinolone Antibiotic Players Market Share by Revenue in 2024
- 3.8.3 2024 Quinolone Antibiotic Tier 1, Tier 2, and Tier 3
- 4 Quinolone Antibiotic Market by Type
- 4.1 Quinolone Antibiotic Type Introduction
- 4.1.1 Levofloxacin
- 4.1.2 Ofloxacin
- 4.1.3 Norfloxacin
- 4.1.4 Moxifloxacin
- 4.1.5 Gatifloxacin
- 4.1.6 Ciprofloxacin
- 4.1.7 Others
- 4.2 Global Quinolone Antibiotic Sales by Type
- 4.2.1 Global Quinolone Antibiotic Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Quinolone Antibiotic Sales by Type (2020-2031)
- 4.2.3 Global Quinolone Antibiotic Sales Market Share by Type (2020-2031)
- 4.3 Global Quinolone Antibiotic Revenue by Type
- 4.3.1 Global Quinolone Antibiotic Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Quinolone Antibiotic Revenue by Type (2020-2031)
- 4.3.3 Global Quinolone Antibiotic Revenue Market Share by Type (2020-2031)
- 5 Quinolone Antibiotic Market by Application
- 5.1 Quinolone Antibiotic Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospital
- 5.1.3 Research
- 5.1.4 Others
- 5.2 Global Quinolone Antibiotic Sales by Application
- 5.2.1 Global Quinolone Antibiotic Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Quinolone Antibiotic Sales by Application (2020-2031)
- 5.2.3 Global Quinolone Antibiotic Sales Market Share by Application (2020-2031)
- 5.3 Global Quinolone Antibiotic Revenue by Application
- 5.3.1 Global Quinolone Antibiotic Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Quinolone Antibiotic Revenue by Application (2020-2031)
- 5.3.3 Global Quinolone Antibiotic Revenue Market Share by Application (2020-2031)
- 6 Global Quinolone Antibiotic Sales by Region
- 6.1 Global Quinolone Antibiotic Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Quinolone Antibiotic Sales by Region (2020-2031)
- 6.2.1 Global Quinolone Antibiotic Sales by Region (2020-2025)
- 6.2.2 Global Quinolone Antibiotic Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Quinolone Antibiotic Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Quinolone Antibiotic Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Quinolone Antibiotic Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Quinolone Antibiotic Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Quinolone Antibiotic Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Quinolone Antibiotic Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Quinolone Antibiotic Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Quinolone Antibiotic Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Quinolone Antibiotic Revenue by Region
- 7.1 Global Quinolone Antibiotic Revenue by Region
- 7.1.1 Global Quinolone Antibiotic Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Quinolone Antibiotic Revenue by Region (2020-2025)
- 7.1.3 Global Quinolone Antibiotic Revenue by Region (2026-2031)
- 7.1.4 Global Quinolone Antibiotic Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Quinolone Antibiotic Revenue (2020-2031)
- 7.2.2 North America Quinolone Antibiotic Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Quinolone Antibiotic Revenue (2020-2031)
- 7.3.2 Europe Quinolone Antibiotic Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Quinolone Antibiotic Revenue (2020-2031)
- 7.4.2 Asia-Pacific Quinolone Antibiotic Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Quinolone Antibiotic Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Quinolone Antibiotic Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Comapny Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Quinolone Antibiotic Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Merck Quinolone Antibiotic Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Hebei Guangren Pharmaceutical Technology
- 8.2.1 Hebei Guangren Pharmaceutical Technology Comapny Information
- 8.2.2 Hebei Guangren Pharmaceutical Technology Business Overview
- 8.2.3 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Product Portfolio
- 8.2.5 Hebei Guangren Pharmaceutical Technology Recent Developments
- 8.3 Tianjin Glory Technology
- 8.3.1 Tianjin Glory Technology Comapny Information
- 8.3.2 Tianjin Glory Technology Business Overview
- 8.3.3 Tianjin Glory Technology Quinolone Antibiotic Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Tianjin Glory Technology Quinolone Antibiotic Product Portfolio
- 8.3.5 Tianjin Glory Technology Recent Developments
- 8.4 Mercury Medicare
- 8.4.1 Mercury Medicare Comapny Information
- 8.4.2 Mercury Medicare Business Overview
- 8.4.3 Mercury Medicare Quinolone Antibiotic Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Mercury Medicare Quinolone Antibiotic Product Portfolio
- 8.4.5 Mercury Medicare Recent Developments
- 8.5 Healthy Life Pharma
- 8.5.1 Healthy Life Pharma Comapny Information
- 8.5.2 Healthy Life Pharma Business Overview
- 8.5.3 Healthy Life Pharma Quinolone Antibiotic Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Healthy Life Pharma Quinolone Antibiotic Product Portfolio
- 8.5.5 Healthy Life Pharma Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Quinolone Antibiotic Value Chain Analysis
- 9.1.1 Quinolone Antibiotic Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Quinolone Antibiotic Production Mode & Process
- 9.2 Quinolone Antibiotic Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Quinolone Antibiotic Distributors
- 9.2.3 Quinolone Antibiotic Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


